Concluding weeks of speculation, overnight Johnson & Johnson announced it agreed to acquire Actelion Pharmaceuticals, Europe’s biggest biotech company, for $30 billion, or CHF280 per share, expanding the U.S. pharma giant’s portfolio of rare-disease treatments as its top-selling drug faces new competition.
After coming out of a 2016 Presidential election cycle in which one candidate was the subject of multiple federal investigations related to illegal pay-to-play activities as well as the illegal destruction of federal records subject to a Congressional subpoena, perhaps it shouldn't be so shocking that the United States was ranked 18th on Transparency International's 2016 "Corruption Perceptions Index." But irrespective of our expectations, here is how the United States stacks up against other countries in terms of mass corruption of our publicly elected officials and the institutions they
Submitted by Daniel Lazare via The Strategic Culture Foundation,
Last week as Donald Trump was preparing to take office, The New York Times — reeling from Trump’s interview in which he said he didn’t “really care” if the European Union holds together and described NATO as “obsolete” — declared that “the big winner” of the change in U.S. presidents was Vladimir Putin.
Dear Bernie, as you continue in your never-ending "Fight for $15", we thought you might benefit from a simple example of how economics work in a real life, functioning, capitalistic society. You see, Bernie, labor, much like your daily serving of crunchy granola, is just another "good" that businesses can choose to consume more or less of, depending on price. And, just to be crystal clear, when the price of labor (i.e.
Authored by Alastair Crooke, originally posted at The Automatic Earth blog,